Ira Targoff to Autoantibodies
This is a "connection" page, showing publications Ira Targoff has written about Autoantibodies.
Connection Strength
5.213
-
SDS-PAGE for ³5S immunoprecipitation and immunoprecipitation western blotting. Methods Mol Biol. 2012; 869:215-33.
Score: 0.315
-
Autoantibodies and their significance in myositis. Curr Rheumatol Rep. 2008 Aug; 10(4):333-40.
Score: 0.248
-
Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase. Arthritis Rheum. 2007 Apr; 56(4):1295-303.
Score: 0.226
-
A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum. 2006 Nov; 54(11):3682-9.
Score: 0.220
-
Myositis specific autoantibodies. Curr Rheumatol Rep. 2006 Jun; 8(3):196-203.
Score: 0.214
-
Idiopathic inflammatory myopathy: autoantibody update. Curr Rheumatol Rep. 2002 Oct; 4(5):434-41.
Score: 0.166
-
Anti-MDA5 autoantibodies associated with juvenile dermatomyositis constitute a distinct phenotype in North America. Rheumatology (Oxford). 2021 04 06; 60(4):1839-1849.
Score: 0.149
-
Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies. RMD Open. 2020 09; 6(2).
Score: 0.143
-
Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis. Ann Rheum Dis. 2019 07; 78(7):988-995.
Score: 0.131
-
The association of anti-Ro52 autoantibodies with myositis and scleroderma autoantibodies. J Autoimmun. 1999 Mar; 12(2):137-42.
Score: 0.129
-
Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. J Immunol. 1999 Feb 15; 162(4):2315-20.
Score: 0.129
-
Features distinguishing clinically amyopathic juvenile dermatomyositis from juvenile dermatomyositis. Rheumatology (Oxford). 2018 11 01; 57(11):1956-1963.
Score: 0.126
-
The effect of cigarette smoking on the clinical and serological phenotypes of polymyositis and dermatomyositis. Semin Arthritis Rheum. 2018 12; 48(3):504-512.
Score: 0.120
-
Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis. Ann Rheum Dis. 2018 05; 77(5):714-719.
Score: 0.120
-
Association of Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis Patients. Arthritis Care Res (Hoboken). 2017 07; 69(7):1088-1094.
Score: 0.115
-
Autoantibodies in sera from patients with L-tryptophan-associated eosinophilia-myalgia syndrome. Demonstration of unique antigen-antibody specificities. Clin Immunol Immunopathol. 1995 Aug; 76(2):115-9.
Score: 0.101
-
Analysis of the Mi-2 autoantigen of dermatomyositis. Arthritis Rheum. 1995 Jan; 38(1):123-8.
Score: 0.097
-
Immune manifestations of inflammatory muscle disease. Rheum Dis Clin North Am. 1994 Nov; 20(4):857-80.
Score: 0.096
-
Brief report: ultraviolet radiation exposure is associated with clinical and autoantibody phenotypes in juvenile myositis. Arthritis Rheum. 2013 Jul; 65(7):1934-41.
Score: 0.087
-
The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore). 2013 Jul; 92(4):223-243.
Score: 0.087
-
Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase. J Clin Invest. 1993 Jun; 91(6):2556-64.
Score: 0.087
-
Antibodies to glycyl-transfer RNA synthetase in patients with myositis and interstitial lung disease. Arthritis Rheum. 1992 Jul; 35(7):821-30.
Score: 0.081
-
Autoantibodies in polymyositis. Rheum Dis Clin North Am. 1992 May; 18(2):455-82.
Score: 0.080
-
Polymyositis. Immunol Ser. 1991; 54:201-46.
Score: 0.073
-
Environmental factors preceding illness onset differ in phenotypes of the juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford). 2010 Dec; 49(12):2381-90.
Score: 0.072
-
Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase). Am J Med. 1990 Mar; 88(3):241-51.
Score: 0.069
-
Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine. Two additional synthetases are antigenic in myositis. J Immunol. 1990 Mar 01; 144(5):1737-43.
Score: 0.069
-
Autoimmune T cell responses to antigenic peptides presented by bronchoalveolar lavage cell HLA-DR molecules in sarcoidosis. Clin Immunol. 2009 Dec; 133(3):353-63.
Score: 0.067
-
Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women. Arthritis Rheum. 2009 Aug; 60(8):2499-504.
Score: 0.067
-
Anti-KJ: a new antibody associated with the syndrome of polymyositis and interstitial lung disease. J Clin Invest. 1989 Jul; 84(1):162-72.
Score: 0.066
-
Immunoprecipitation-western blot for proteins of low abundance. Methods Mol Biol. 2009; 536:259-75.
Score: 0.064
-
Antibody to threonyl-transfer RNA synthetase in myositis sera. Arthritis Rheum. 1988 Apr; 31(4):515-24.
Score: 0.061
-
Laboratory manifestations of polymyositis/dermatomyositis. Clin Dermatol. 1988 Apr-Jun; 6(2):76-92.
Score: 0.061
-
Measurement of antibody to Jo-1 by ELISA and comparison to enzyme inhibitory activity. J Immunol. 1987 May 01; 138(9):2874-82.
Score: 0.057
-
Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies. Medicine (Baltimore). 2006 Mar; 85(2):111-127.
Score: 0.052
-
Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups. Arthritis Rheum. 2005 Aug; 52(8):2433-8.
Score: 0.050
-
The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum. 1985 Jul; 28(7):796-803.
Score: 0.050
-
Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine (Baltimore). 2005 Jul; 84(4):231-249.
Score: 0.050
-
Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease. Arthritis Rheum. 2003 Aug; 48(8):2285-93.
Score: 0.044
-
Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features. Rheumatology (Oxford). 2023 02 23; 62(SI2):SI226-SI234.
Score: 0.043
-
Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies. Rheum Dis Clin North Am. 2002 Nov; 28(4):859-90, viii.
Score: 0.042
-
Low copy numbers of complement C4 and C4A deficiency are risk factors for myositis, its subgroups and autoantibodies. Ann Rheum Dis. 2023 Feb; 82(2):235-245.
Score: 0.041
-
Association of anti-HSC70 autoantibodies with cutaneous ulceration and severe disease in juvenile dermatomyositis. Rheumatology (Oxford). 2022 07 06; 61(7):2969-2977.
Score: 0.041
-
Environmental factors associated with juvenile idiopathic inflammatory myopathy clinical and serologic phenotypes. Pediatr Rheumatol Online J. 2022 Apr 12; 20(1):28.
Score: 0.040
-
Update on myositis-specific and myositis-associated autoantibodies. Curr Opin Rheumatol. 2000 Nov; 12(6):475-81.
Score: 0.036
-
Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies. Arthritis Res Ther. 2020 04 06; 22(1):69.
Score: 0.035
-
Antiendothelial cell antibodies in inflammatory myopathies: distribution among clinical and serologic groups and association with interstitial lung disease. J Rheumatol. 2000 Jan; 27(1):161-4.
Score: 0.034
-
Detection of anti-PL-12 autoantibodies by ELISA using a recombinant antigen; study of the immunoreactive region. Clin Exp Immunol. 1998 Nov; 114(2):161-5.
Score: 0.032
-
Medications received by patients with juvenile dermatomyositis. Semin Arthritis Rheum. 2018 12; 48(3):513-522.
Score: 0.030
-
Classification criteria for the idiopathic inflammatory myopathies. Curr Opin Rheumatol. 1997 Nov; 9(6):527-35.
Score: 0.029
-
Anti-endothelial cell antibody, thrombomodulin, and von Willebrand factor in idiopathic inflammatory myopathies. Clin Diagn Lab Immunol. 1997 Sep; 4(5):519-21.
Score: 0.029
-
Autoantibodies to ribosomal P proteins penetrate into live hepatocytes and cause cellular dysfunction in culture. J Immunol. 1997 Aug 15; 159(4):2033-41.
Score: 0.029
-
Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies. Arthritis Rheum. 1997 Jul; 40(7):1257-66.
Score: 0.029
-
Atorvastatin-induced necrotizing autoimmune myositis: An emerging dominant entity in patients with autoimmune myositis presenting with a pure polymyositis phenotype. Medicine (Baltimore). 2017 Jan; 96(3):e5694.
Score: 0.028
-
Clinical significance of specific autoantibodies in juvenile dermatomyositis. J Rheumatol. 1996 Oct; 23(10):1794-7.
Score: 0.027
-
Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis. Arthritis Rheum. 1996 Sep; 39(9):1507-18.
Score: 0.027
-
Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis. Semin Arthritis Rheum. 1996 Aug; 26(1):459-67.
Score: 0.027
-
Brief Report: Association of Myositis Autoantibodies, Clinical Features, and Environmental Exposures at Illness Onset With Disease Course in Juvenile Myositis. Arthritis Rheumatol. 2016 Mar; 68(3):761-8.
Score: 0.026
-
Autoantibodies to glycyl-transfer RNA synthetase in myositis. Association with dermatomyositis and immunologic heterogeneity. Arthritis Rheum. 1996 Jan; 39(1):146-51.
Score: 0.026
-
Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen. J Clin Invest. 1995 Oct; 96(4):1730-7.
Score: 0.025
-
Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features. Medicine (Baltimore). 2014 Nov; 93(24):318-332.
Score: 0.024
-
A broadened spectrum of juvenile myositis. Myositis-specific autoantibodies in children. Arthritis Rheum. 1994 Oct; 37(10):1534-8.
Score: 0.024
-
Autoantibodies to a transfer RNA-associated protein in a murine model of chronic graft versus host disease. J Immunol. 1994 Feb 15; 152(4):1989-99.
Score: 0.023
-
Humoral immunity in polymyositis/dermatomyositis. J Invest Dermatol. 1993 Jan; 100(1):116S-123S.
Score: 0.021
-
The clinical phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore). 2013 Jan; 92(1):25-41.
Score: 0.021
-
A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore). 1991 Nov; 70(6):360-74.
Score: 0.019
-
Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies. Arthritis Rheum. 1991 Nov; 34(11):1391-6.
Score: 0.019
-
Immune mechanisms in myositis. Curr Opin Rheumatol. 1990 Dec; 2(6):882-8.
Score: 0.018
-
HLA-D region genes associated with autoantibody responses to histidyl-transfer RNA synthetase (Jo-1) and other translation-related factors in myositis. Arthritis Rheum. 1990 Aug; 33(8):1240-8.
Score: 0.018
-
Diagnosis and treatment of polymyositis and dermatomyositis. Compr Ther. 1990 Apr; 16(4):16-24.
Score: 0.017
-
Humoral immunity in polymyositis and dermatomyositis. Mt Sinai J Med. 1988 Nov; 55(6):487-93.
Score: 0.016
-
Immunoglobulin gene polymorphisms are susceptibility factors in clinical and autoantibody subgroups of the idiopathic inflammatory myopathies. Arthritis Rheum. 2008 Oct; 58(10):3239-46.
Score: 0.016
-
Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity. Medicine (Baltimore). 2008 Mar; 87(2):70-86.
Score: 0.015
-
HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies. Arthritis Rheum. 2006 Nov; 54(11):3670-81.
Score: 0.014
-
Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes. J Clin Immunol. 1984 Jan; 4(1):40-4.
Score: 0.011
-
Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy. Arthritis Rheum. 1998 Apr; 41(4):710-9.
Score: 0.008
-
NIH conference. Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy. Ann Intern Med. 1995 May 01; 122(9):715-24.
Score: 0.006
-
Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy. Am J Med. 1993 Apr; 94(4):379-87.
Score: 0.005